{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T05:28:15Z","timestamp":1781155695246,"version":"3.54.1"},"reference-count":36,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DDDT"],"DOI":"10.2147\/dddt.s404182","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:18:17Z","timestamp":1682036297000},"page":"1203-1210","source":"Crossref","is-referenced-by-count":5,"title":["A Comparison of the Pharmacokinetics and Safety of Dapagliflozin Formate, an Ester Prodrug of Dapagliflozin, to Dapagliflozin Propanediol Monohydrate in Healthy Subjects"],"prefix":"10.2147","volume":"Volume 17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8819-4780","authenticated-orcid":true,"given":"Hyun Chul","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangmi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyoung","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2309-4420","authenticated-orcid":true,"given":"Eunjin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8384-3139","authenticated-orcid":true,"given":"In-Jin","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4188-2786","authenticated-orcid":true,"given":"Jae-Yong","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice C. 2. classification and diagnosis of diabetes: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S17\u2013S38. doi:10.2337\/dc22-S002","DOI":"10.2337\/dc22-S002"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.4093\/dmj.2021.0156","volume":"45","author":"Hur","year":"2021","journal-title":"Diabetes Metab J"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000439364","volume":"31","author":"Melmer","year":"2016","journal-title":"Endocr Dev"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5897\/JPAP2013.0001","volume":"4","author":"Ozougwu","year":"2013","journal-title":"J Physiol Pathophysiol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1136\/postgradmedj-2015-133281","volume":"92","author":"Zaccardi","year":"2016","journal-title":"Postgrad Med J"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1055\/a-1018-9078","volume":"127","author":"Petersmann","year":"2019","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.2337\/dc22-S009","volume":"45","author":"Draznin","year":"2022","journal-title":"Diabetes Care"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/PHAR.1010","volume":"32","author":"Shah","year":"2012","journal-title":"Pharmacotherapy"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s13300-014-0089-4","volume":"5","author":"Kalra","year":"2014","journal-title":"Diabetes Ther"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1080\/14656566.2021.1953471","volume":"22","author":"Nicholson","year":"2021","journal-title":"Expert Opin Pharmacother"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/7355_2014_41","volume":"12","author":"Braem","year":"2014","journal-title":"Carbohydr Drugs"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ejps.2017.04.008","volume":"104","author":"Deng","year":"2017","journal-title":"Eur J Pharm Sci"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics13010070","volume":"13","author":"Cho","year":"2021","journal-title":"Pharmaceutics"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.ijpharm.2016.07.017","volume":"511","author":"LaCreta","year":"2016","journal-title":"Int J Pharm"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1111\/jphp.12384","volume":"67","author":"Domingos","year":"2015","journal-title":"J Pharm Pharmacol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.addr.2017.03.002","volume":"117","author":"Healy","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.addr.2007.05.013","volume":"59","author":"Stella","year":"2007","journal-title":"Adv Drug Deliv Rev"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1016\/j.xphs.2015.11.004","volume":"105","author":"Rumondor","year":"2016","journal-title":"J Pharm Sci"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.ejmech.2016.10.061","volume":"127","author":"Abet","year":"2017","journal-title":"Eur J Med Chem"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/17425247.2019.1553954","volume":"16","author":"Najjar","year":"2019","journal-title":"Expert Opin Drug Deliv"},{"key":"ref21","unstructured":"U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research. Bioequivalence studies with pharmacokinetic endpoints for drugs submitted under an ANDA: draft guidance for industry; August 2021."},{"key":"ref22","unstructured":"European Medicines Agency, Committee for Medicinal Products for Human Use (CHMP). Guideline on the Investigation of Bioequivalence. January 20, 2010."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ejps.2018.10.019","volume":"127","author":"Chen","year":"2019","journal-title":"Eur J Pharm Sci"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.clinthera.2013.06.017","volume":"35","author":"Yang","year":"2013","journal-title":"Clin Ther"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s40262-013-0104-3","volume":"53","author":"Kasichayanula","year":"2014","journal-title":"Clin Pharmacokinet"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/j.clinthera.2015.05.004","volume":"37","author":"Chang","year":"2015","journal-title":"Clin Ther"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.clinthera.2018.02.006","volume":"40","author":"Khomitskaya","year":"2018","journal-title":"Clin Ther"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ejim.2014.02.011","volume":"25","author":"Martens","year":"2014","journal-title":"Eur J Intern Med"},{"key":"ref29","volume-title":"Hypoglycemia","year":"2021"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.apsb.2018.05.005","volume":"8","author":"Wang","year":"2018","journal-title":"Acta Pharm Sin B"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1002\/jps.23182","volume":"101","author":"Ohura","year":"2012","journal-title":"J Pharm Sci"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"793","DOI":"10.2174\/138920010794328904","volume":"11","author":"Imai","year":"2010","journal-title":"Curr Drug Metab"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"70","DOI":"10.2174\/187231209788654081","volume":"3","author":"Berry","year":"2009","journal-title":"Drug Metab Lett"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1021\/cb800065s","volume":"3","author":"Lavis","year":"2008","journal-title":"ACS Chemical Biology"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3390\/ph2030077","volume":"2","author":"Wu","year":"2009","journal-title":"Pharmaceuticals"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tox.2007.04.005","volume":"236","author":"Wu","year":"2007","journal-title":"Toxicology"}],"container-title":["Drug Design, Development and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=89148","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=89148","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:18:24Z","timestamp":1682036304000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/a-comparison-of-the-pharmacokinetics-and-safety-of-dapagliflozin-forma-peer-reviewed-fulltext-article-DDDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":36,"URL":"https:\/\/doi.org\/10.2147\/dddt.s404182","relation":{},"ISSN":["1177-8881"],"issn-type":[{"value":"1177-8881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4]]}}}